- Home
- DMRC vs TERN Comparison
DMRC vs TERN Comparison
Compare DMRC & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMRC
- TERN
- Stock Information
- Founded
- DMRC 2008
- TERN 2017
- Country
- DMRC United States
- TERN United States
- Employees
- DMRC N/A
- TERN 59
- Industry
- DMRC EDP Services
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- DMRC Technology
- TERN Health Care
- Exchange
- DMRC Nasdaq
- TERN Nasdaq
- Market Cap
- DMRC 279.8M
- TERN 310.8M
- IPO Year
- DMRC N/A
- TERN 2021
- Fundamental
- Price
- DMRC $13.37
- TERN $3.23
- Analyst Decision
- DMRC Buy
- TERN Buy
- Analyst Count
- DMRC 2
- TERN 5
- Target Price
- DMRC $30.00
- TERN $18.38
- AVG Volume (30 Days)
- DMRC 205.6K
- TERN 1.0M
- Earning Date
- DMRC 05-05-2025
- TERN 05-16-2025
- Dividend Yield
- DMRC N/A
- TERN N/A
- EPS Growth
- DMRC N/A
- TERN N/A
- EPS
- DMRC N/A
- TERN N/A
- Revenue
- DMRC $37,848,000.00
- TERN N/A
- Revenue This Year
- DMRC N/A
- TERN N/A
- Revenue Next Year
- DMRC N/A
- TERN N/A
- P/E Ratio
- DMRC N/A
- TERN N/A
- Revenue Growth
- DMRC 2.44
- TERN N/A
- 52 Week Low
- DMRC $10.44
- TERN $1.87
- 52 Week High
- DMRC $48.32
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- DMRC 52.17
- TERN 58.41
- Support Level
- DMRC $11.76
- TERN $2.93
- Resistance Level
- DMRC $14.27
- TERN $3.62
- Average True Range (ATR)
- DMRC 0.78
- TERN 0.25
- MACD
- DMRC 0.32
- TERN 0.05
- Stochastic Oscillator
- DMRC 81.76
- TERN 69.20
About DMRC Digimarc Corporation
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers, and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.